Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.
Age range
21 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Outcome Comparison Survey
Timeframe: The end of the study (Week 20 to 25)
Participant Satisfaction Survey
Timeframe: From first post-treatment follow-up visit to the last follow-up visit at week 16 to week 25
Imaging Assessment
Timeframe: From first pre-treatment visit to the last follow-up visit at week 16 to week 25
Case Report Form
Timeframe: The report will be completed at the end of the study (Week 20 to 25), but highlights would be recorded in this document during every visit.
Visit Evaluation Report
Timeframe: From first post-treatment follow-up visit to the last follow-up visit at week 16 to week 25